prof. dr. Sarah Gerlo

Conference Paper

CXCR4-Tropic HIV-1 Shapes Unique Immunopathology and Larger Reservoir

Kavita Mehta (UGent) , Twan Otten, Victoria Rios Vazquez, Mareva Delporte (UGent) , Maxime Verschoore (UGent) , Evy Blomme (UGent) , Sarah Gerlo (UGent) , Casper Rokx, Janneke Stalenhoef, Marvin Berrevoets, et al.

(2026)

Add to list

Click-chemistry functionalized lipid nanoparticles for in vitro and in vivo transfection of primary human CD4+ T cells

Maaike De Cock (UGent) , Elianne Burg (UGent) , Sarah Gerlo (UGent) , Linos Vandekerckhove (UGent) , Bruno De Geest (UGent) and Jolien Van Cleemput (UGent)

(2026) ADVANCED HEALTHCARE MATERIALS.

Add to list

Journal Article
A1
open access

Broadly neutralizing antibody-secreting CAR-T cells elicit Fc-mediated effector functions in vitro and suppress HIV in humanized mice

Zoi Stylianidou (UGent) , Sarah Gerlo (UGent) , Magdalena Wejda (UGent) , Elianne Burg (UGent) , Evelien De Smet (UGent) , Ytse Noppe (UGent) , Maxime Verschoore (UGent) , Jolien Van Cleemput (UGent) , Linos Vandekerckhove (UGent) and Wojciech Witkowski (UGent)

(2026) FRONTIERS IN IMMUNOLOGY. 17.

Add to list

Journal Article
A1
open access

CD4-directed nanoblades enable selective genome editing in CD4+ cells and HIV suppression in vitro and in vivo

Jolien Van Cleemput (UGent) , Maaike De Cock (UGent) , Rianne Verbeek (UGent) , Elianne Burg (UGent) , Bram Van Den Eeckhout (UGent) , Wojciech Witkowski (UGent) , Willem van Snippenberg, Zoi Stylianidou (UGent) , Emily Brugger Galetic (UGent) , Mareva Delporte (UGent) , et al.

(2026) EMBO MOLECULAR MEDICINE. 18. p.3345-3373

Add to list

Making the cut : CD4-targeted lipid nanoparticles for CRISPR-Cas9-mediated HIV cure

Maaike De Cock (UGent) , Elianne Burg (UGent) , Sarah Gerlo (UGent) , Bruno De Geest (UGent) , Linos Vandekerckhove (UGent) and Jolien Van Cleemput (UGent)

(2026) Nucleic Acid Therapeutics and Targeted Delivery, Keystone symposium, Abstracts.

Add to list

Journal Article
A1
open access

HIV-1 virome profiling using HIV-PULSE to guide therapeutic and curative interventions

Sofie De Braekeleer (UGent) , Laurens Lambrechts, Liesbet Termote (UGent) , Mareva Delporte (UGent) , Kavita Mehta (UGent) , Vasiliki Matzaraki, Evy Blomme (UGent) , Philippe Lemey, Bram Vrancken, Casper Rokx, et al.

(2026) EBIOMEDICINE. 128.

Add to list

Virulent HIV-1B : clinical challenges and proteomic insights

Kavita Mehta (UGent) , Mareva Delporte (UGent) , Victoria Rios Vazquez, Marc J. T Blaauw, Louise E. van Eekeren, Albert L. Groenendijk, Wilhelm A Vos, Evy Blomme (UGent) , Sarah Gerlo (UGent) , Bram Vrancken, et al.

(2025) Abstract eBook 32nd Conference on Retroviruses and Opportunistic Infections (CROI 2025). p.79-79

Add to list

Journal Article
A1
open access

Blood and tissue HIV-1 reservoirs display plasticity and lack of compartmentalization in virally suppressed people

Marion Pardons (UGent) , Laurens Lambrechts, Ytse Noppe (UGent) , Liesbet Termote (UGent) , Sofie De Braekeleer (UGent) , Jerel Vega, Ellen Van Gulck, Sarah Gerlo (UGent) and Linos Vandekerckhove (UGent)

(2025) NATURE COMMUNICATIONS. 16(1).

Add to list

Journal Article
A1
open access

Integrative assessment of total and intact HIV-1 reservoir by a 5-region multiplexed rainbow DNA digital PCR assay

Mareva Delporte (UGent) , Laurens Lambrechts, Evy Blomme (UGent) , Willem van Snippenberg, Sofie Rutsaert (UGent) , Maxime Verschoore (UGent) , Evelien De Smet (UGent) , Ytse Noppe (UGent) , Nele De Langhe (UGent) , Marie-Angélique De Scheerder (UGent) , et al.

(2025) CLINICAL CHEMISTRY. 71(1). p.203-214

Add to list

Journal Article
A1
open access

In-depth analysis of the HIV reservoir confirms effectiveness and safety of dolutegravir/lamivudine in a phase 4 randomized controlled switch trial (RUMBA)

Marie-Angélique De Scheerder (UGent) , Sophie Degroote (UGent) , Mareva Delporte (UGent) , Maja Kiselinova (UGent) , Wim Trypsteen (UGent) , Lara Vincke, Evelien De Smet (UGent) , Bram Van Den Eeckhout (UGent) , Loic Schrooyen (UGent) , Maxime Verschoore (UGent) , et al.

(2024) JOURNAL OF INFECTIOUS DISEASES. 231(1). p.e91-e100

Academic Bibliography

prof. dr. Sarah Gerlo

CXCR4-Tropic HIV-1 Shapes Unique Immunopathology and Larger Reservoir

Click-chemistry functionalized lipid nanoparticles for in vitro and in vivo transfection of primary human CD4+ T cells

Broadly neutralizing antibody-secreting CAR-T cells elicit Fc-mediated effector functions in vitro and suppress HIV in humanized mice

CD4-directed nanoblades enable selective genome editing in CD4+ cells and HIV suppression in vitro and in vivo

Making the cut : CD4-targeted lipid nanoparticles for CRISPR-Cas9-mediated HIV cure

HIV-1 virome profiling using HIV-PULSE to guide therapeutic and curative interventions

Virulent HIV-1B : clinical challenges and proteomic insights

Blood and tissue HIV-1 reservoirs display plasticity and lack of compartmentalization in virally suppressed people

Integrative assessment of total and intact HIV-1 reservoir by a 5-region multiplexed rainbow DNA digital PCR assay

In-depth analysis of the HIV reservoir confirms effectiveness and safety of dolutegravir/lamivudine in a phase 4 randomized controlled switch trial (RUMBA)

Contents

Support

Contact